Sign In
Buy REPH
$0.675
+0 (+0%)
At Close: Aug 17, 2022
Is the Options Market Predicting a Spike in Recro Pharma (REPH) Stock?
09:47am, Tuesday, 15'th Dec 2020
Investors need to pay close attention to Recro Pharma (REPH) stock based on the movements in the options market lately.
Recro Pharma, Inc. (REPH) CEO Geraldine Henwood on Q3 2020 Results - Earnings Call Transcript
12:14am, Tuesday, 10'th Nov 2020
Recro Pharma, Inc. (REPH) CEO Geraldine Henwood on Q3 2020 Results - Earnings Call Transcript
Recro Reports Third Quarter 2020 Financial Results
07:00am, Monday, 09'th Nov 2020
Company Secures Three-Year Renewal of Licens e and Supply Agreement with Lannett , A Generic s Pharmaceutical Company, for Manufacturing of Verelan PM ® , Verelan SR ® and Verapamil PM
